PolicyEngage does not support browsers with JavaScript disabled and some functionality may be missing, please follow these steps to enable it.

{{$root.universalMessage.text}}

Alaska HB216

GENE THERAPY PRODUCT DISCLOSURE

Link to Summary Link to Summary

Link to Full Text Link to Full Text

On January 16, 2024 in the House:

READ THE FIRST TIME - REFERRALS
HSS, L&C
REFERRED TO HEALTH & SOCIAL SERVICES

AK - Representative David Eastman (R)

Type:

Primary Sponsor

Show previous .

Participants:

{{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }} {{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }}

{{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }}

{{discussion.createdAt}} | delete | deleting | edit | cancel

Nothing posted by your team.

Select categories:

X

Clear all